Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $3.54 million. The enterprise value is -$9.91 million.
Important Dates
The last earnings date was Monday, June 15, 2026, after market close.
| Earnings Date | Jun 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 1.49 million shares outstanding. The number of shares has increased by 930.62% in one year.
| Current Share Class | 1.49M |
| Shares Outstanding | 1.49M |
| Shares Change (YoY) | +930.62% |
| Shares Change (QoQ) | +159.84% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 5.67% |
| Float | 1.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.22 |
| P/TBV Ratio | 0.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.79, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.79 |
| Quick Ratio | 4.73 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -716.77 |
Financial Efficiency
Return on equity (ROE) is -114.61% and return on invested capital (ROIC) is -72.73%.
| Return on Equity (ROE) | -114.61% |
| Return on Assets (ROA) | -51.35% |
| Return on Invested Capital (ROIC) | -72.73% |
| Return on Capital Employed (ROCE) | -70.18% |
| Weighted Average Cost of Capital (WACC) | -2.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $17,723 in taxes.
| Income Tax | 17,723 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.34% in the last 52 weeks. The beta is -1.24, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.24 |
| 52-Week Price Change | -99.34% |
| 50-Day Moving Average | 4.70 |
| 200-Day Moving Average | 101.48 |
| Relative Strength Index (RSI) | 33.20 |
| Average Volume (20 Days) | 4,695,581 |
Short Selling Information
The latest short interest is 40,505, so 2.73% of the outstanding shares have been sold short.
| Short Interest | 40,505 |
| Short Previous Month | 205,330 |
| Short % of Shares Out | 2.73% |
| Short % of Float | 2.73% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.10M |
| Pretax Income | -7.89M |
| Net Income | -7.90M |
| EBITDA | -8.08M |
| EBIT | -8.10M |
| Earnings Per Share (EPS) | -$71.49 |
Full Income StatementBalance Sheet
The company has $13.59 million in cash and $85,588 in debt, giving a net cash position of $13.51 million or $9.09 per share.
| Cash & Cash Equivalents | 13.59M |
| Total Debt | 85,588 |
| Net Cash | 13.51M |
| Net Cash Per Share | $9.09 |
| Equity (Book Value) | 11.49M |
| Book Value Per Share | 11.28 |
| Working Capital | 11.33M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.22M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 10,954 |
| Net Borrowing | 6.75M |
| Free Cash Flow | -6.22M |
| FCF Per Share | -$4.19 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |